Mothaffar F. Rimawi, M.D.
Dr. Rimawi is Professor of Medicine, co-Leader of the Breast Cancer Research Program, and Executive Medical Director of the Dan L Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine. He received his medical degree from the University of Jordan and completed his internal medicine, Medical Oncology, and Breast Oncology at Baylor College of Medicine.
His research interest is in translational clinical trials and biomarkers of response and resistance. Dr. Rimawi has designed and led multiple prominent national and international trials in breast cancer with a particular focus on HER2+ and ER+ breast cancer. His work helped promote dual HER2 inhibition, concurrent targeting of ER, and treatment de-escalation. His research is funded by grants from the National Cancer Institute, the Department of Defense Breast Research Program, and several foundations.
He serves on multiple national clinical research leadership committees, including the Breast Committee of the NRG Oncology Group. He is co-Chair of the HER2 Working group of the Translational Breast Cancer Symposium (TBCRC).
